{
    "xml": "<topic id=\"PHP1001\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/nadolol\" basename=\"nadolol\" title=\"NADOLOL\">\n<title>NADOLOL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_452\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/nadolol\">Nadolol</xref>\n</p>\n<data name=\"vtmid\">82896009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_613648210\" title=\"Beta-adrenoceptor blockers\">Beta-adrenoceptor blockers</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP64462\" outputclass=\"indicationsAndDose\" rev=\"1.30\" parent=\"/drugs/nadolol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertension</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 80&#8239;mg once daily, then increased in steps of up to 80&#8239;mg every 1&#8239;week if required, doses higher than the maximum are rarely necessary; maximum 240&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Angina</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg once daily, then increased if necessary up to 160&#8239;mg daily, doses should be increased at weekly intervals, maximum dose rarely is used; maximum 240&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Arrhythmias</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg once daily, then increased if necessary up to 160&#8239;mg once daily, doses should be increased at weekly intervals; reduced to 40&#8239;mg daily if bradycardia occurs.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Migraine prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg once daily, then increased in steps of 40&#8239;mg every 1&#8239;week, adjusted according to response; maintenance 80&#8211;160&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Thyrotoxicosis (adjunct)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>80&#8211;160&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64903\" outputclass=\"breastFeeding\" parent=\"/drugs/nadolol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Water soluble beta-blockers such as nadolol are present in breast milk in greater amounts than other beta blockers.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64492\" outputclass=\"hepaticImpairment\" parent=\"/drugs/nadolol\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64300\" outputclass=\"renalImpairment\" parent=\"/drugs/nadolol\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Increase dosage interval if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1001-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/nadolol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension, tablet</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75946\" title=\"Tablet\" namespace=\"/drugs/nadolol/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78218\" namespace=\"/treatment-summaries/beta-adrenoceptor-blocking-drugs\" title=\"Beta-adrenoceptor blocking drugs\" count=\"2\" rel=\"backlink\">Beta-adrenoceptor blocking drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78238\" namespace=\"/treatment-summaries/migraine\" title=\"Migraine\" count=\"1\" rel=\"backlink\">Migraine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78280\" namespace=\"/treatment-summaries/antithyroid-drugs\" title=\"Antithyroid drugs\" count=\"1\" rel=\"backlink\">Antithyroid drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_452\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/nadolol\" title=\"Nadolol\" count=\"1\" rel=\"link\">Nadolol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" count=\"1\" rel=\"link\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75946\" namespace=\"/drugs/nadolol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP1001",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/nadolol",
    "basename": "nadolol",
    "title": "NADOLOL",
    "interactants": [
        {
            "id": "bnf_int_452",
            "label": "Nadolol"
        }
    ],
    "vtmid": "82896009",
    "drugClassification": [
        "Beta-adrenoceptor blockers"
    ],
    "inheritsFromClass": [
        "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Hypertension",
                        "html": "Hypertension"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 80 mg once daily, then increased in steps of up to 80 mg every 1 week if required, doses higher than the maximum are rarely necessary; maximum 240 mg per day.",
                        "html": "<p>Initially 80&#8239;mg once daily, then increased in steps of up to 80&#8239;mg every 1&#8239;week if required, doses higher than the maximum are rarely necessary; maximum 240&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Angina",
                        "html": "Angina"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg once daily, then increased if necessary up to 160 mg daily, doses should be increased at weekly intervals, maximum dose rarely is used; maximum 240 mg per day.",
                        "html": "<p>Initially 40&#8239;mg once daily, then increased if necessary up to 160&#8239;mg daily, doses should be increased at weekly intervals, maximum dose rarely is used; maximum 240&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg once daily, then increased if necessary up to 160 mg once daily, doses should be increased at weekly intervals; reduced to 40 mg daily if bradycardia occurs.",
                        "html": "<p>Initially 40&#8239;mg once daily, then increased if necessary up to 160&#8239;mg once daily, doses should be increased at weekly intervals; reduced to 40&#8239;mg daily if bradycardia occurs.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Migraine prophylaxis",
                        "html": "Migraine prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg once daily, then increased in steps of 40 mg every 1 week, adjusted according to response; maintenance 80&#8211;160 mg once daily.",
                        "html": "<p>Initially 40&#8239;mg once daily, then increased in steps of 40&#8239;mg every 1&#8239;week, adjusted according to response; maintenance 80&#8211;160&#8239;mg once daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Thyrotoxicosis (adjunct)",
                        "html": "Thyrotoxicosis (adjunct)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "80&#8211;160 mg once daily.",
                        "html": "<p>80&#8211;160&#8239;mg once daily.</p>"
                    }
                ]
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Water soluble beta-blockers such as nadolol are present in breast milk in greater amounts than other beta blockers.",
                "html": "<p>Water soluble beta-blockers such as nadolol are present in breast milk in greater amounts than other beta blockers.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution.",
                "html": "<p>Manufacturer advises caution.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Increase dosage interval if eGFR less than 50 mL/minute/1.73 m2.",
                "html": "<p>Increase dosage interval if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension",
                "tablet"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75946",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78218",
                "label": "Beta-adrenoceptor blocking drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78238",
                "label": "Migraine",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78280",
                "label": "Antithyroid drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_452",
                "label": "Nadolol",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34515",
                "label": "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75946",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}